New insider activity at Becton Dickinson ( (BDX) ) has taken place on November 7, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Director Bertram Scott recently executed a transaction involving the sale of 217 shares of Becton Dickinson stock, amounting to a total value of $38,317.
Recent Updates on BDX stock
Becton, Dickinson and Co (BDX) has announced updates on several ongoing clinical studies, which could have significant market implications. The BD Prevue II Peripheral Vascular Access System study aims to improve catheter placement accuracy and safety, potentially boosting sales and influencing competitor strategies. The BD SiteRite 9 Ultrasound System study seeks to enhance VAD insertion precision, which could increase investor confidence in BDX’s innovative technologies. The BACTEC™ Plus Aerobic/F Culture Vials study focuses on improving sepsis diagnostics, potentially strengthening BDX’s diagnostic market position. Lastly, the BD PosiFlush™ SafeScrub study aims to reduce catheter-related bloodstream infections, enhancing BDX’s competitive edge in the medical device industry. These developments may positively impact BDX’s stock performance by demonstrating technological advancements and expanding its product portfolio.
Spark’s Take on BDX Stock
According to Spark, TipRanks’ AI Analyst, BDX is a Outperform.
Becton Dickinson’s overall stock score reflects strong earnings call performance and strategic initiatives, offset by challenges in valuation and technical analysis. The company’s solid financial performance and operational efficiency are notable, but profitability and cash flow issues present areas for improvement. Market headwinds and tariff impacts are risks to monitor.
To see Spark’s full report on BDX stock, click here.
More about Becton Dickinson
YTD Price Performance: -20.55%
Average Trading Volume: 1,946,787
Technical Sentiment Signal: Strong Sell
Current Market Cap: $50.56B